Therapies for ALL and AML targeting MER receptor hold promise of more effect with less side-effect

Studies show that the protein receptor Mer is overexpressed in many leukemias, and that inhibition of this Mer receptor results in the death of leukemia cells — without affecting surrounding, healthy cells.